Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,301 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by doclevel, 12-05-2011, 05:59 PM
|
0 responses
1,488 views
0 reactions
|
Last Post
by doclevel
12-05-2011, 05:59 PM
|
||
|
Started by cllorens, 12-01-2011, 07:57 AM
|
0 responses
1,452 views
0 reactions
|
Last Post
by cllorens
12-01-2011, 07:57 AM
|
||
|
Started by Raa, 11-30-2011, 11:47 PM
|
0 responses
1,174 views
0 reactions
|
Last Post
by Raa
11-30-2011, 11:47 PM
|
||
|
Started by haidan, 11-29-2011, 10:46 PM
|
0 responses
1,546 views
0 reactions
|
Last Post
by haidan
11-29-2011, 10:46 PM
|
||
|
Started by isildur, 11-28-2011, 06:44 AM
|
1 response
1,337 views
0 reactions
|
Last Post
|
||
|
Started by maen, 11-24-2011, 06:12 AM
|
0 responses
1,052 views
0 reactions
|
Last Post
by maen
11-24-2011, 06:12 AM
|
||
|
Started by snakesgun, 11-09-2011, 09:25 PM
|
3 responses
1,625 views
0 reactions
|
Last Post
by andyding
11-24-2011, 12:30 AM
|
||
|
hi
by gianluca.occhi
Started by gianluca.occhi, 11-22-2011, 08:51 AM
|
0 responses
1,019 views
0 reactions
|
Last Post
|
||
|
Started by kimleon, 11-21-2011, 11:32 PM
|
0 responses
1,132 views
0 reactions
|
Last Post
by kimleon
11-21-2011, 11:32 PM
|
||
|
Started by chinky, 11-17-2011, 09:58 PM
|
1 response
1,266 views
0 reactions
|
Last Post
by coffee52
11-21-2011, 12:10 AM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
widgetinstance 229 (<!-- ##phrase_widget_229_searchTitle_0## -->) skipped due to lack of content & hide_module_if_empty option.
Recent Articles
Collapse
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 09:51 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Today, 09:51 AM
|
||
|
Started by SEQadmin2, 09-25-2026, 09:06 AM
|
0 responses
32 views
0 reactions
|
Last Post
by SEQadmin2
09-25-2026, 09:06 AM
|
||
|
Started by SEQadmin2, 09-23-2026, 11:05 AM
|
0 responses
27 views
0 reactions
|
Last Post
by SEQadmin2
09-23-2026, 11:05 AM
|